Vireo Raising $31.5mm to Expand its Pharmaceutical Grade Medical Cannabis Operations

vireo health medical products

Operating under one of the two licenses for medical cannabis in Minnesota and one of five in New York, Vireo Health is in the process of raising up to $31.5mm to expand into up to twenty additional states.

States Vireo will target next include Maryland, Georgia and Pennsylvania, plus those with large populations, like Texas and Florida.

The company reports a strong start to its efforts, receiving positive responses from wealthy individuals interested in investing in the medical cannabis industry.  Vireo Health stated its intentions to conduct clinical trials with the FDA after announcing a licensing agreement with Ligand Pharmaceuticals (NASDAQ: LGND) in November.

Read Katharine Grayson’s “Medical-marijuana startup Vireo raising $31.5M to expand into more states”:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter